Industrial Bank Healthcare Fund: A Comprehensive Guide (000831)76

Industrial Bank Healthcare Fund (000831) is a closed-end fund that invests primarily in healthcare and pharmaceutical companies in China. The fund is managed by Industrial Bank Fund Management Co., Ltd. and was established in 2009. As of March 2023, the fund had a total net asset value of approximately RMB 14.2 billion (USD 2.1 billion).

The fund's investment objective is to achieve long-term capital appreciation by investing in a diversified portfolio of healthcare and pharmaceutical companies in China. The fund invests in a range of companies, including those involved in pharmaceuticals, biotechnology, medical devices, and healthcare services. The fund's portfolio is actively managed by a team of experienced investment professionals who conduct thorough research and analysis to identify potential investment opportunities.

The fund has a proven track record of delivering strong returns to investors. Over the past five years, the fund has generated an annualized return of over 10%. The fund's performance has been driven by the strong growth of the healthcare sector in China. China's healthcare market is one of the largest and fastest-growing in the world, and is expected to continue to grow rapidly in the coming years. This growth is being driven by a number of factors, including the increasing demand for healthcare services from China's rapidly aging population, the rising prevalence of chronic diseases, and the government's increasing support for the healthcare sector.

The fund is suitable for investors who are looking for exposure to the healthcare sector in China. The fund is a good option for investors who are looking for a diversified portfolio of healthcare stocks, as well as for investors who are looking for a fund with a proven track record of delivering strong returns. However, investors should be aware that the fund is subject to investment risks, including the risk of losing money.

Fund Highlights* Investment objective: To achieve long-term capital appreciation by investing in a diversified portfolio of healthcare and pharmaceutical companies in China.
* Management: The fund is managed by Industrial Bank Fund Management Co., Ltd.
* Track record: The fund has a proven track record of delivering strong returns to investors. Over the past five years, the fund has generated an annualized return of over 10%.
* Risks: The fund is subject to investment risks, including the risk of losing money.

Who Should Invest in the Fund?* Investors who are looking for exposure to the healthcare sector in China.
* Investors who are looking for a diversified portfolio of healthcare stocks.
* Investors who are looking for a fund with a proven track record of delivering strong returns.

Risks to Consider* The fund is subject to investment risks, including the risk of losing money.
* The healthcare sector is subject to a number of risks, including the risk of regulatory changes and the risk of competition.
* The Chinese economy is subject to a number of risks, including the risk of economic slowdown.

2024-11-05

Previous：Zhejiang Provincial Mental Health Promotion Association

Next：Kids Nutrition Recipe Tutorial Videos